title: Thyroid eye disease--medical or surgical therapy?
abstract: Thyroid eye disease is autoimmune in nature and associated with Graves' Disease. Autoantibodies to the 64 kDa antigen in thyroid membranes cross-react to the 64 kDa proteins in human eye muscle membranes. Antibody dependent cell mediated cytotoxicity against eye muscle cells are also found in patients with thyroid eye disease. The purpose of this paper is to review the treatment available and to share the authors' experience using cyclosporin A. In the majority of cases, thyroid eye disease is mild, manifest only as bilateral or unilateral proptosis, with/without grittiness of the eyes. This is usually treated conservatively with eye drops. If proptosis is more severe and there is incomplete closure of eyelids, epiphora and conjunctival injection, then lateral tarrsorrhaphy is usually effective, combined with use of eye pads and eye drops. The problem of diplopia can be treated conservatively with special lenses, or with surgical correction of tethered muscles. However when proptosis is severe, with raised intraocular pressure, severe chemosis and danger of blindness, then the choice of therapy is controversial: rapid decompression by surgical means or use of high doses of prednisolone. Most prefer prednisolone therapy initially, surgical decompression if it fails. Various other methods have been tried, aimed at the immunological nature of the disease, namely plasmapheresis, radiotherapy and immunosuppressive drugs such as cyclosporin, with variable success. Our experience with cyclosporin had been mixed and inconclusive.
authors.affiliation: Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur.
authors.forename: B A
authors.initials: BA
authors.lastname: Khalid
authors.forename: M L
authors.initials: ML
authors.lastname: Ng
mesh_terms: D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use; D005128:Eye Diseases / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D006111:Graves Disease / Q000150:complications*; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use; D010956:Plasmapheresis; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D013965:Thyroidectomy
chemical_list: D003524:Cyclosporins; D007457:Iodine Radioisotopes; D011239:Prednisolone